Connor, Clark & Lunn Investment Management Ltd. Eli Lilly & CO Transaction History

Connor, Clark & Lunn Investment Management Ltd.

$21.8 Billion
Q1 2024

A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Eli Lilly & CO stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 49,581 shares of LLY stock, worth $44.9 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares

49,581

Previous 65,085 23.82%

Holding current value

$44.9 Million

Previous $37.9 Million 1.67%

% of portfolio

0.18%

Previous 0.19%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	SELL	$592.2 - $792.28 $9.18 Million - $12.3 Million	-15,504 Reduced 23.82%	49,581 $38.6 Million
Q4 2023 Feb 09, 2024	SELL	$525.19 - $619.13 $24 Million - $28.3 Million	-45,630 Reduced 41.21%	65,085 $37.9 Million
Q3 2023 Nov 13, 2023	BUY	$434.7 - $599.3 $42.7 Million - $58.8 Million	98,154 Added 781.42%	110,715 $59.5 Million
Q2 2023 Aug 10, 2023	SELL	$350.74 - $468.98 $9.36 Million - $12.5 Million	-26,685 Reduced 67.99%	12,561 $5.89 Million
Q1 2023 May 09, 2023	SELL	$310.63 - $364.82 $7.35 Million - $8.63 Million	-23,654 Reduced 37.61%	39,246 $13.5 Million

Q4 2022 Feb 10, 2023	SELL	$321.55 - $374.67 $3.34 Million - $3.89 Million	-10,391 Reduced 14.18%	62,900 $23 Million
Q3 2022 Nov 10, 2022	SELL	$296.48 - $337.87 $34.9 Million - $39.8 Million	-117,819 Reduced 61.65%	73,291 $23.7 Million
Q2 2022 Aug 05, 2022	SELL	$278.73 - $327.27 $4.45 Million - $5.22 Million	-15,954 Reduced 7.7%	191,110 $62 Million
Q1 2022 May 12, 2022	BUY	$234.69 - $291.66 $21.4 Million - $26.6 Million	91,244 Added 78.78%	207,064 $59.3 Million
Q4 2021 Feb 10, 2022	SELL	$224.85 - $279.04 $9.29 Million - $11.5 Million	-41,328 Reduced 26.3%	115,820 $32 Million
Q3 2021 Nov 12, 2021	SELL	$221.6 - $272.71 $6.21 Million - $7.64 Million	-28,028 Reduced 15.14%	157,148 $36.3 Million
Q2 2021 Aug 12, 2021	SELL	$180.55 - $233.54 $9.8 Million - $12.7 Million	-54,254 Reduced 22.66%	185,176 $42.5 Million
Q1 2021 May 13, 2021	BUY	$164.32 - $212.72 $25.5 Million - $33 Million	155,211 Added 184.29%	239,430 $44.7 Million
Q4 2020 Feb 16, 2021	SELL	$130.46 - $172.63 $12.9 Million - $17.1 Million	-99,018 Reduced 54.04%	84,219 $14.2 Million
Q3 2020 Nov 12, 2020	BUY	$146.22 - $169.13 $14.3 Million - $16.6 Million	98,100 Added 115.23%	183,237 $27.1 Million
Q2 2020 Aug 13, 2020	BUY	$136.42 - $164.18 $1.24 Million - $1.49 Million	9,071 Added 11.93%	85,137 $14 Million
Q4 2019 Feb 12, 2020	SELL	$106.92 - $132.43 $23.7 Million - $29.3 Million	-221,500 Reduced 74.44%	76,066 $10 Million
Q3 2019 Nov 13, 2019	SELL	$106.79 - $116.16 $8.03 Million - $8.73 Million	-75,159 Reduced 20.16%	297,566 $33.3 Million
Q2 2019 Aug 07, 2019	BUY	$110.79 - $129.32 $19.4 Million - $22.6 Million	174,975 Added 88.48%	372,725 $41.3 Million
Q1 2019 May 08, 2019	BUY	$111.31 - $131.02 $22 Million - $25.9 Million	197,750 New	197,750 $25.7 Million
Q2 2018 Aug 02, 2018	SELL	$75.7 - $86.88 $7.01 Million - $8.04 Million	-92,575 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$74.21 - $87.6 $1.87 Million - $2.21 Million	25,175 Added 37.35%	92,575 $7.16 Million
Q4 2017 Feb 09, 2018	SELL	$81.94 - $87.89 $979,183 - $1.05 Million	-11,950 Reduced 15.06%	67,400 $5.69 Million
Q3 2017 Nov 14, 2017	BUY	$77.07 - $85.54 $6.12 Million - $6.79 Million	79,350	79,350 $6.79 Million

Others Institutions Holding LLY

# of Institutions

3,719

Shares Held

738M

Call Options Held

7.09M

Put Options Held

7.24M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $860B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Account

Connor, Clark & Lunn Investment Management Ltd. Eli Lilly & CO Transaction History